Protective Effect of Resveratrol on Retinal Damage in Glaucoma: a Systematic Review and Meta-analysis of Preclinical Studies

Overview

Journal Front Pharmacol

Date 2025 Jan 30

PMID 39881870

Authors

Feng Zhang

Tao Li

Junli Wan

Lu Wang

Wenmei Guo

Yue Hu

Hao Wang

Wei Bian

Affiliations

Soon will be listed here.

Abstract

Introduction: Resveratrol, a polyphenolic compound commonly found in natural plants and fruits, exhibits potential in preventing optic nerve damage in glaucoma, as indicated by several animal studies. However, there is presently a dearth of relevant evidence available for comprehensive summarization.

Methods: In this study, we conducted an extensive search across 7 electronic databases, encompassing all pertinent animal studies for a systematic review and meta-analysis. Methodological quality was evaluated using SYRCLE's bias risk tool, with statistical analysis performed using Stata 17.0. The primary outcome measures included the survival of retinal ganglion cells and retinal thickness.

Results: The comprehensive analysis of the 30 included studies revealed that resveratrol can enhance the expression of Sirtuin 1(SIRT1) protein in retinal tissue (SMD: 3.00, 95% CI: 2.46, 3.53, P = 0.095), boost the survival rate of retinal ganglion cells (SMD: 4.33, 95% CI: 3.28, 5.38, P < 0.05), decelerate the thinning of retinal thickness (SMD: 4.26, 95% CI: 2.77, 5.75, P < 0.05), and enhance visual function. Its potential mechanism of action may involve the suppression of pro-inflammatory cytokine levels and cell apoptosis.

Discussion: Resveratrol emerges as a promising agent for mitigating glaucoma-related retinal damage. However, given that the animal research models utilized in the study may not fully reflect the intricate scenarios of multiple coexisting diseases in clinical settings, and the administration methods in animal models may differ from those in clinical practice, future studies should aim to provide higher levels of evidence to facilitate the clinical translation of these findings.

Systematic Review Registration: identifier [CRD42024535673].

References

Deng C, Chen S, Li X, Luo H, Zhang Q, Hu P . Role of the PGE2 receptor in ischemia-reperfusion injury of the rat retina. Mol Vis. 2020; 26:36-47. PMC: 7043643. View

Chen H, Deng Y, Gan X, Li Y, Huang W, Lu L . NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodegener. 2020; 15(1):26. PMC: 7161290. DOI: 10.1186/s13024-020-00372-w. View

Libby R, Li Y, Savinova O, Barter J, Smith R, Nickells R . Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005; 1(1):17-26. PMC: 1183523. DOI: 10.1371/journal.pgen.0010004. View

Delmas D, Cornebise C, Courtaut F, Xiao J, Aires V . New Highlights of Resveratrol: A Review of Properties against Ocular Diseases. Int J Mol Sci. 2021; 22(3). PMC: 7865717. DOI: 10.3390/ijms22031295. View

Wu Y, Pang Y, Wei W, Shao A, Deng C, Li X . Resveratrol protects retinal ganglion cell axons through regulation of the SIRT1-JNK pathway. Exp Eye Res. 2020; 200:108249. DOI: 10.1016/j.exer.2020.108249. View

Seong H, Ryu J, Yoo W, Kim S, Han Y, Park J . Resveratrol Ameliorates Retinal Ischemia/Reperfusion Injury in C57BL/6J Mice via Downregulation of Caspase-3. Curr Eye Res. 2017; 42(12):1650-1658. DOI: 10.1080/02713683.2017.1344713. View

Liu B, Neufeld A . Activation of epidermal growth factor receptor signals induction of nitric oxide synthase-2 in human optic nerve head astrocytes in glaucomatous optic neuropathy. Neurobiol Dis. 2003; 13(2):109-23. DOI: 10.1016/s0969-9961(03)00010-x. View

Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer E . Inflammation in Glaucoma: From the back to the front of the eye, and beyond. Prog Retin Eye Res. 2020; 83:100916. DOI: 10.1016/j.preteyeres.2020.100916. View

Zhou M, Luo J, Zhang H . Role of Sirtuin 1 in the pathogenesis of ocular disease (Review). Int J Mol Med. 2018; 42(1):13-20. DOI: 10.3892/ijmm.2018.3623. View

10.

Pirhan D, Yuksel N, Emre E, Cengiz A, Yildiz D . Riluzole- and Resveratrol-Induced Delay of Retinal Ganglion Cell Death in an Experimental Model of Glaucoma. Curr Eye Res. 2015; 41(1):59-69. DOI: 10.3109/02713683.2015.1004719. View

11.

Zalewska R, Reszec J, Mariak Z, Sulkowski S . [The expression of Bcl-2, Bcl-xl, Bak and Bax proteins in axons of the optic nerve in closed-angle glaucoma]. Klin Oczna. 2004; 106(1-2 Suppl):155-7. View

12.

Lancon A, Frazzi R, Latruffe N . Anti-Oxidant, Anti-Inflammatory and Anti-Angiogenic Properties of Resveratrol in Ocular Diseases. Molecules. 2016; 21(3):304. PMC: 6272926. DOI: 10.3390/molecules21030304. View

13.

Pang Y, Qin M, Hu P, Ji K, Xiao R, Sun N . Resveratrol protects retinal ganglion cells against ischemia induced damage by increasing Opa1 expression. Int J Mol Med. 2020; 46(5):1707-1720. PMC: 7521588. DOI: 10.3892/ijmm.2020.4711. View

14.

Prager A, Liebmann J, Cioffi G, Blumberg D . Self-reported Function, Health Resource Use, and Total Health Care Costs Among Medicare Beneficiaries With Glaucoma. JAMA Ophthalmol. 2016; 134(4):357-65. DOI: 10.1001/jamaophthalmol.2015.5479. View

15.

Kim B, Braun T, Wordinger R, Clark A . Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice. Mol Neurodegener. 2013; 8:21. PMC: 3695831. DOI: 10.1186/1750-1326-8-21. View

16.

Zuo L, Khan R, Lee V, Dine K, Wu W, Shindler K . SIRT1 promotes RGC survival and delays loss of function following optic nerve crush. Invest Ophthalmol Vis Sci. 2013; 54(7):5097-102. PMC: 3726244. DOI: 10.1167/iovs.13-12157. View

17.

Chitranshi N, Rajput R, Godinez A, Pushpitha K, Mirzaei M, Basavarajappa D . Neuroserpin gene therapy inhibits retinal ganglion cell apoptosis and promotes functional preservation in glaucoma. Mol Ther. 2023; 31(7):2056-2076. PMC: 10362384. DOI: 10.1016/j.ymthe.2023.03.008. View

18.

Seong H, Jeong J, Ryu J, Park J, Han Y, Cho H . Resveratrol prevents hypoxia-induced retinal ganglion cell death related with ErbB2. Int J Ophthalmol. 2022; 15(3):394-400. PMC: 8907051. DOI: 10.18240/ijo.2022.03.04. View

19.

Katai N, Yoshimura N . Apoptotic retinal neuronal death by ischemia-reperfusion is executed by two distinct caspase family proteases. Invest Ophthalmol Vis Sci. 1999; 40(11):2697-705. View

20.

Goldblum D, Mittag T . Prospects for relevant glaucoma models with retinal ganglion cell damage in the rodent eye. Vision Res. 2002; 42(4):471-8. DOI: 10.1016/s0042-6989(01)00194-8. View